| Evaluation of machine-learning algorithms for predicting opioid overdose risk among medicare beneficiaries with opioid prescriptions WH Lo-Ciganic, JL Huang, HH Zhang, JC Weiss, Y Wu, CK Kwoh, ... JAMA network open 2 (3), e190968-e190968, 2019 | 190 | 2019 |
| Caring for opioid-dependent pregnant women: prenatal and postpartum care considerations EE Krans, G Cochran, DL Bogen Clinical obstetrics and gynecology 58 (2), 370-379, 2015 | 122 | 2015 |
| Association between trajectories of buprenorphine treatment and emergency department and in‐patient utilization WH Lo‐Ciganic, WF Gellad, AJ Gordon, G Cochran, MA Zemaitis, ... Addiction 111 (5), 892-902, 2016 | 110 | 2016 |
| Psychosocial predictors in the transition from acute to chronic pain: a systematic review V Hruschak, G Cochran Psychology, health & medicine 23 (10), 1151-1167, 2018 | 88 | 2018 |
| Excessive opioid prescribing after major urologic procedures KM Theisen, JM Myrga, N Hale, G Cochran, C Sewall, LC Macleod, ... Urology 123, 101-107, 2019 | 76 | 2019 |
| Medication-assisted treatment and opioid use before and after overdose in Pennsylvania Medicaid W Frazier, G Cochran, WH Lo-Ciganic, WF Gellad, AJ Gordon, ... Jama 318 (8), 750-752, 2017 | 76 | 2017 |
| Patterns and quality of buprenorphine opioid agonist treatment in a large Medicaid program AJ Gordon, WH Lo-Ciganic, G Cochran, WF Gellad, T Cathers, D Kelley, ... Journal of addiction medicine 9 (6), 470-477, 2015 | 71 | 2015 |
| An examination of claims-based predictors of overdose from a large Medicaid program G Cochran, AJ Gordon, WH Lo-Ciganic, WF Gellad, W Frazier, C Lobo, ... Medical care 55 (3), 291-298, 2017 | 70 | 2017 |
| The role of primary care in improving access to medication-assisted treatment for rural Medicaid enrollees with opioid use disorder ES Cole, E DiDomenico, G Cochran, AJ Gordon, WF Gellad, J Pringle, ... Journal of General Internal Medicine 34, 936-943, 2019 | 64 | 2019 |
| Pharmacists who screen and discuss opioid misuse with patients: future directions for research and practice G Cochran, C Field, K Lawson Journal of pharmacy practice 28 (4), 404-412, 2015 | 53 | 2015 |
| Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists G Cochran, C Field, K Lawson, C Erickson Journal of Pharmaceutical Health Services Research 4 (2), 71-79, 2013 | 50 | 2013 |
| Medication treatment for opioid use disorder and community pharmacy: expanding care during a national epidemic and global pandemic G Cochran, J Bruneau, N Cox, AJ Gordon Substance abuse 41 (3), 269-274, 2020 | 46 | 2020 |
| Frequent experience of LGBQ microaggression on campus associated with smoking among sexual minority college students T Ylioja, G Cochran, MR Woodford, KA Renn Nicotine and tobacco research 20 (3), 340-346, 2018 | 45 | 2018 |
| Defining nonmedical use of prescription opioids within health care claims: a systematic review G Cochran, B Woo, WH Lo-Ciganic, AJ Gordon, JM Donohue, WF Gellad Substance abuse 36 (2), 192-202, 2015 | 45 | 2015 |
| Developing a framework of care for opioid medication misuse in community pharmacy G Cochran, AJ Gordon, C Field, J Bacci, R Dhital, T Ylioja, M Stitzer, ... Research in Social and Administrative Pharmacy 12 (2), 293-301, 2016 | 44 | 2016 |
| Risk factors for symptoms of prescription opioid misuse: do older adults differ from younger adult patients? G Cochran, D Rosen, RM McCarthy, RJ Engel Journal of gerontological social work 60 (6-7), 443-457, 2017 | 41 | 2017 |
| Screening community pharmacy patients for risk of prescription opioid misuse G Cochran, J Rubinstein, JL Bacci, T Ylioja, R Tarter Journal of addiction medicine 9 (5), 411-416, 2015 | 41 | 2015 |
| Prescription opioid use: patient characteristics and misuse in community pharmacy G Cochran, JL Bacci, T Ylioja, V Hruschak, S Miller, AL Seybert, R Tarter Journal of the American Pharmacists association 56 (3), 248-256. e6, 2016 | 37 | 2016 |
| Web-based treatment for substance use disorders: Differential effects by primary substance G Cochran, M Stitzer, ANC Campbell, MC Hu, R Vandrey, EV Nunes Addictive behaviors 45, 191-194, 2015 | 35 | 2015 |
| A community pharmacy-led intervention for opioid medication misuse: a small-scale randomized clinical trial G Cochran, Q Chen, C Field, AL Seybert, V Hruschak, A Jaber, AJ Gordon, ... Drug and alcohol dependence 205, 107570, 2019 | 34 | 2019 |
Adam J GordonUniversity of UtahVerified email at hsc.utah.edu
